Cargando…
Molecular mechanism of lysophosphatidic acid-induced hypertensive response
Lysophosphatidic acid (LPA) is a blood-derived bioactive lipid with numerous biological activities exerted mainly through six defined G protein-coupled receptors (LPA(1)-LPA(6)). LPA was first identified as a vasoactive compound because it induced transient hypertension when injected intravenously i...
Autores principales: | Kano, Kuniyuki, Matsumoto, Hirotaka, Inoue, Asuka, Yukiura, Hiroshi, Kanai, Motomu, Chun, Jerold, Ishii, Satoshi, Shimizu, Takao, Aoki, Junken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389983/ https://www.ncbi.nlm.nih.gov/pubmed/30804442 http://dx.doi.org/10.1038/s41598-019-39041-4 |
Ejemplares similares
-
Autotaxin Overexpression Causes Embryonic Lethality and Vascular Defects
por: Yukiura, Hiroshi, et al.
Publicado: (2015) -
LPP3 localizes LPA(6) signalling to non-contact sites in endothelial cells
por: Yukiura, Hiroshi, et al.
Publicado: (2015) -
Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification
por: Kano, Kuniyuki, et al.
Publicado: (2021) -
Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain
por: Ma, Lin, et al.
Publicado: (2009) -
Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
por: Inoue, Makoto, et al.
Publicado: (2008)